Active Ingredient: NILOTINIB
(Hérité de NILOTINIB ACCORD 200 mg)
https://www.fda.gov/media/178811/download, https://doi.org/10.1016/j.ctrv.2017.11.009, https://doi.org/10.18632/oncotarget.25008, https://doi.org/10.1161/CIR.0000000000001056, https://doi.org/10.1093/eurheartj/ehab362, https://doi.org/10.1016/S1470-2045(22)00221-2, https://doi.org/10.1007/s40264-013-0047-5